Back
Diebold Nixdorf, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
84
DBD
Diebold Nixdorf, Inc.
Last Price:
$67.63
Seasonality Move:
11.65%
Buy
65
GPCR
Structure Therapeutics, Inc.
Last Price:
$66.48
Seasonality Move:
-40.78%
Buy
84
Diebold Nixdorf, Inc. (DBD)
is a Buy
Is Diebold Nixdorf, Inc. a Buy, Sell or Hold?
-
The current Diebold Nixdorf, Inc. [DBD] share price is $67.65. The Score for DBD is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
DBD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
65
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $67.44. The Score for GPCR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DBD Stock Price Chart
What is Diebold Nixdorf, Inc.'s stock price today?
-
The Diebold Nixdorf, Inc. share price today is $67.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBD is experiencing slight buying pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $67.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
DBD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 65.38 | Buy |
| Chaikin Money Flow: | 1359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.69 - 66.31) | Buy |
| Bollinger Bands (100): | (56.97 - 63.45) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.09 | Buy |
| Relative Strength Index (14 RSI): | 78.81 | Buy |
| Chaikin Money Flow: | -1662506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.48 - 52.38) | Buy |
| Bollinger Bands (100): | (16.92 - 37.88) | Buy |
DBD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.01 | Buy |
| 20-day SMA: | 64.35 | Buy |
| 50-day SMA: | 61.14 | Buy |
| 200-day SMA: | 54.05 | Buy |
| 8-day EMA: | 66.03 | Buy |
| 20-day EMA: | 64.59 | Buy |
| 50-day EMA: | 62.28 | Buy |
| 200-day EMA: | 55.47 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.53 | Buy |
| 20-day SMA: | 41.36 | Buy |
| 50-day SMA: | 34.58 | Buy |
| 200-day SMA: | 24.42 | Buy |
| 8-day EMA: | 55.53 | Buy |
| 20-day EMA: | 45.05 | Buy |
| 50-day EMA: | 36.57 | Buy |
| 200-day EMA: | 28.49 | Buy |
Diebold Nixdorf, Inc. Earnings Growth & DBD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.89 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
Diebold Nixdorf, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||